New England Research & Management Raised Its Wells Fargo (WFC) Holding; Lifepoint Hospitals Has 0.82 Sentiment

Wells Fargo & Company (NYSE:WFC) Logo

Lifepoint Hospitals Inc (LPNT) investors sentiment decreased to 0.82 in Q4 2017. It’s down -0.48, from 1.3 in 2017Q3. The ratio dropped, as 84 investment managers started new and increased positions, while 103 cut down and sold equity positions in Lifepoint Hospitals Inc. The investment managers in our database now hold: 40.34 million shares, down from 40.50 million shares in 2017Q3. Also, the number of investment managers holding Lifepoint Hospitals Inc in top ten positions was flat from 0 to 0 for the same number . Sold All: 32 Reduced: 71 Increased: 58 New Position: 26.

New England Research & Management Inc increased Wells Fargo (WFC) stake by 17.1% reported in 2017Q4 SEC filing. New England Research & Management Inc acquired 5,150 shares as Wells Fargo (WFC)’s stock declined 16.98%. The New England Research & Management Inc holds 35,260 shares with $2.14 million value, up from 30,110 last quarter. Wells Fargo now has $251.20B valuation. The stock decreased 0.50% or $0.26 during the last trading session, reaching $51.54. About 19.22M shares traded. Wells Fargo & Company (NYSE:WFC) has declined 7.75% since May 4, 2017 and is downtrending. It has underperformed by 19.30% the S&P500.

More news for LifePoint Health, Inc. (NASDAQ:LPNT) were recently published by: Benzinga.com, which released: “Earnings Scheduled For May 4, 2018” on May 04, 2018. Globenewswire.com‘s article titled: “LifePoint Health To Broadcast Its First Quarter 2018 Conference Call Live On The Internet” and published on April 13, 2018 is yet another important article.

Ratings analysis reveals 0 of Lifepoint Hospitals’s analysts are positive. Out of 6 Wall Street analysts rating Lifepoint Hospitals, 0 give it “Buy”, 1 “Sell” rating, while 5 recommend “Hold”. The lowest target is $57.0 while the high is $68.0. The stock’s average target of $62.50 is 23.40% above today’s ($50.65) share price. LPNT was included in 6 notes of analysts from November 9, 2016. The firm has “Underperform” rating given on Wednesday, November 9 by Bank of America. Mizuho maintained LifePoint Health, Inc. (NASDAQ:LPNT) rating on Tuesday, February 21. Mizuho has “Neutral” rating and $57.0 target. Deutsche Bank initiated it with “Hold” rating and $68.0 target in Wednesday, April 5 report. The stock has “Mkt Perform” rating by Avondale on Wednesday, November 9. The stock of LifePoint Health, Inc. (NASDAQ:LPNT) earned “Neutral” rating by Credit Suisse on Friday, November 11. The rating was initiated by Piper Jaffray on Wednesday, January 4 with “Neutral”.

LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. The company has market cap of $1.97 billion. The Company’s hospitals offer a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric services, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. It has a 20.18 P/E ratio. The companyÂ’s hospitals also provide various outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy.

Profit Investment Management Llc holds 1.65% of its portfolio in LifePoint Health, Inc. for 43,304 shares. Dean Capital Management owns 54,438 shares or 1.28% of their US portfolio. Moreover, Sivik Global Healthcare Llc has 1.02% invested in the company for 55,000 shares. The New York-based New Amsterdam Partners Llc Ny has invested 0.97% in the stock. Smith Graham & Co. Investment Advisors Lp, a Texas-based fund reported 205,780 shares.

The stock increased 0.10% or $0.05 during the last trading session, reaching $50.65. About 518,717 shares traded. LifePoint Health, Inc. (LPNT) has declined 25.67% since May 4, 2017 and is downtrending. It has underperformed by 37.22% the S&P500.

More notable recent Wells Fargo & Company (NYSE:WFC) news were published by: Seekingalpha.com which released: “Wells Fargo: Where Is The Upside?” on May 03, 2018, also Seekingalpha.com with their article: “Wells Fargo: Buying Opportunity?” published on April 25, 2018, 247Wallst.com published: “Wells Fargo Settles Federal Claims for $1 Billion” on April 20, 2018. More interesting news about Wells Fargo & Company (NYSE:WFC) were released by: 247Wallst.com and their article: “Analyst Has 3 Top Banks to Buy Going Into Q1 Earnings” published on April 13, 2018 as well as Benzinga.com‘s news article titled: “Banking Fintech Zenmonics Looks To Put Bankers And Clients On The Same Page” with publication date: May 01, 2018.

New England Research & Management Inc decreased Abbvie Inc. (NYSE:ABBV) stake by 4,775 shares to 4,533 valued at $438,000 in 2017Q4. It also reduced Estee Lauder (NYSE:EL) stake by 3,325 shares and now owns 2,700 shares. Dycom Industries (NYSE:DY) was reduced too.

Since November 17, 2017, it had 0 insider purchases, and 1 sale for $292,234 activity. Codel Franklin R had sold 5,393 shares worth $292,234.

LifePoint Health, Inc. (NASDAQ:LPNT) Institutional Positions Chart